KLINGBO
Klingbo is a learning management system (LMS) that is software for the administration, documentation, tracking, reporting, and delivery of educational courses, training programs, or learning and development programs.
KLINGBO
Industry:
E-Learning Education Software Training
Address:
Accra, Greater Accra, Ghana
Country:
Ghana
Website Url:
http://www.klingbo.com
Status:
Active
Contact:
+233 26 859 9554
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Font Awesome Domain Not Resolving Mobile Non Scaleable Content PHP PHP 7
Current Employees Featured
Investors List
MEST Express accelerator
MEST Express accelerator investment in Grant - Klingbo
More informations about "Klingbo"
Kling Biotherapeutics - Crunchbase Company Profile
Kling Biotherapeutics operates as a biotherapeutics discovery and development company. It utilizes a proprietary platform to identify novel antibodies from …See details»
Kling Biotherapeutics - LinkedIn
Kling Biotherapeutics | 1,427 followers on LinkedIn. Amsterdam based biotech developing novel antibody based therapeutics | Kling Biotherapeutics is a clinical-stage, privately held biotech ...See details»
Kling Biotherapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Kling Biotherapeutics. Use the PitchBook Platform to explore the full profile.See details»
Kling Biotherapeutics Strengthens Leadership Team to Advance …
Dec 10, 2024 Kling Biotherapeutics Strengthens Leadership Team to Advance Pipeline Using its Proprietary Primary B-Cell Selection and Evolution Platform Alessandra Micaela Villa …See details»
Kling BioTherapeutics - VentureRadar
"Kling BioTherapeutics is a newly-formed Amsterdam UMC spin-off that is discovering and developing innovative antibody and antibody-derived drugs to treat cancer and infectious …See details»
Kling Biotherapeutics - Products, Competitors, Financials, …
Kling Biotherapeutics is a clinical-stage biotech company focused on the discovery and development of antibody-based therapeutics. Use the CB Insights Platform to explore Kling …See details»
Kling Biotherapeutics BV - Drug pipelines, Patents, Clinical trials ...
Explore Kling Biotherapeutics BV with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 4 news, Disease Domain:Neoplasms, Hemic and ...See details»
Kling Biotherapeutics BV - Amsterdam UMC Ventures Holding
Amsterdam UMC proudly presents new spin-off Kling BioTherapeutics Kling Biotherapeutics BV [email protected] www.klingbio.com Links Algemeen KennisinstellingenSee details»
Pipeline - Kling Biotherapeutics
Kling is developing a growing pipeline of drug candidates that recognize novel targets and epitopes. Our ability to identify functional antibodies and their targets is facilitated by a well-optimized process of target identification paired with …See details»
Klingbo - Funding, Financials, Valuation & Investors - Crunchbase
Klingbo is a management and learning system for educational courses, training programs, and development programs.See details»
Kling BioTherapeutics - VentureRadar
Kling BioTherapeutics is a newly-formed Amsterdam UMC spin-off that is discovering and developing innovative antibody and antibody-derived drugs to treat cancer and infectious …See details»
Kling Biotherapeutics — Time BioVentures | Healthcare and …
May 6, 2022 Kling discovers and develops antibody-based therapeutics by scanning the immune repertoires of patients who have had remarkable outcomes. The company’s proprietary B cell …See details»
Kling Biotherapeutics Appoints Michael Koslowski, M.D. As Chief ...
AMSTERDAM, Dec. 12, 2022 /PRNewswire/ -- Kling Biotherapeutics, B.V., a clinical-stage company pioneering the discovery and development of novel antibody-based therapeutics, …See details»
Klingbo - Products, Competitors, Financials, Employees, …
About Klingbo Klingbo develops a learning management system. The company provides applications for the administration, documentation, monitoring, reporting, and delivery of …See details»
Nextsource | Company Profile | Kling Biotherapeutics
Explore the company profile of Kling Biotherapeutics (klingbio.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Kling Biotherapeutics to Present Key Applications for its Primary B ...
Oct 31, 2024 Kling Biotherapeutics to Present Key Applications for its Primary B-Cell Immortalization, Screening and Antibody Optimization Platform Technologies at PEGS Europe …See details»
News - Kling Biotherapeutics
Sep 29, 2022 Kling Biotherapeutics Strengthens Leadership Team to Advance Pipeline Using its Proprietary Primary B-Cell Selection and Evolution PlatformSee details»
Kling Biotherapeutics to Present Discoveries on its Primary B-Cell ...
Feb 22, 2024 Kling Biotherapeutics to Present Discoveries on its Primary B-Cell Screening Platform at the ESMO Targeted Anticancer Therapies Congress Kling reports on advancing …See details»
Technology - Kling Biotherapeutics
Jan 1, 2010 Technology Groundbreaking B-cell immortalization technology underpins two discovery platforms: Kling-Select and Kling-EvolveSee details»